InvestorsHub Logo
Followers 115
Posts 1939
Boards Moderated 0
Alias Born 11/22/2017

Re: ae kusterer post# 330205

Saturday, 11/14/2020 5:36:22 AM

Saturday, November 14, 2020 5:36:22 AM

Post# of 725141
ae kusterer,

Thank you! Great find.

APPLICATION OF COGNATE BIOSERVICES, INC. FOR EXPANSION PAYMENT-IN-LIEU-OF-TAX BEFORE ECONOMIC DEVELOPMENT GROWTH ENGINE INDUSTRIAL DEVELOPMENT BOARD OF THE CITY OF MEMPHIS AND COUNTY OF SHELBY, TENNESSEE 2020

Cognate’s clients include Atara Biotherapeutics, Inc., a developer of atherapeutic product designed to treat Epstein Barr virus, one of the most common humanviruses in the world, and Northwest Biotherapeutics, Inc., a developer of a patient-specific treatment for Glioblastoma multiforme (“GBM”),the most aggressive and lethal form of brain cancer.
Indeed, Cognate manufactured product for the world’s largest GBM clinical trial. Though Cognate is not the only CDMO in the United States, only a select few have the knowledge, experience and qualified personnel required to manufacture a living cell product from its inception until the moment when it is administered to a patient.Cognate is one of them. The live cell specimens that form these products require careful monitoring, adjustments, quality control, analysis and testing.



https://www.dropbox.com/sh/tlagm94xvkr4eah/AADYWl2TLEu9wzG5P1-nPp9ja?dl=0&preview=Cognate+PILOT+Application.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News